2011 Analytical Chemistry Licensing Treatment 
Drug Discovery World
MARCH 7, 2023
Linda Powers, CEO, Northwest Biotherapeutics Powers has served as the Chairman of NW Bio since 2007, and as CEO since 2011. She has over 15 years’ experience in corporate finance and restructurings, mergers and acquisitions, joint ventures and intellectual property licensing.
The Pharma Data
NOVEMBER 5, 2020
has been appointed to the additional role of president and will oversee the growth of the company’s technology portfolio for the treatment of ischemic and hemorrhagic stroke. Prior to this, he held a position as a director of Analytical Chemistry in Drug Discovery at GlaxoSmithKline. Denner has been with Sarissa since 2011.
Expert insights. Personalized for you.
246 
Let's personalize your content